Cargando…
P1414: CRP IS A CONVENIENT PREDICTIVE MARKER OF THE ANTIPYRETIC EFFECT OF TOCILIZUMAB ON CRS DURING CAR-T CELL THERAPY
Autores principales: | Yokoyama, Shota, Ara, Takahide, Harada, Shinpei, Mori, Yuto, Hasegawa, Yuta, Ohigashi, Hiroyuki, Matsukawa, Toshihiro, Yasumoto, Atsushi, Shiratori, Souichi, Onozawa, Masahiro, Nakagawa, Masao, Kahata, Kaoru, Endo, Tomoyuki, Hashimoto, Daigo, Goto, Hideki, Teshima, Takanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430487/ http://dx.doi.org/10.1097/01.HS9.0000972544.91452.b7 |
Ejemplares similares
-
P1526: THE RISK OF DEVELOPING PNEUMOCYSTIS JIROVECII PNEUMONIA PERSISTS EVEN AFTER COMPLETION OF IMMUNOSUPPRESSANTS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS
por: Ara, Takahide, et al.
Publicado: (2023) -
PB2581: BACILLUS BACTEREMIA IS DETECTED EARLIER THAN OTHER GRAM-POSITIVE RODS IN BLOOD CULTURES OF PATIENTS WITH HEMATOLOGICAL MALIGNANCIES.
por: Mori, Yuto, et al.
Publicado: (2023) -
5-Azacytidine partially restores CD20 expression in follicular lymphoma that lost CD20 expression after rituximab treatment: a case report
por: Tsutsumi, Yutaka, et al.
Publicado: (2016) -
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies
por: Kauer, Joseph, et al.
Publicado: (2020) -
Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript
por: Miyashita, Naoki, et al.
Publicado: (2021)